The complex landscape of smoldering myeloma management continues to challenge oncologists and hematologists, particularly concerning optimal approaches to risk stratification and the precise timing for initiating treatment. As highlighted by Dr. Ajai Chari at the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference, these critical areas remain subjects […]